Latest Breaking News On - First half operating - Page 1 : comparemela.com

It looks like GSK may have found its blockbuster. Arexvy, the world’s first RSV vaccine for older adults has been approved in the U.S. and Japan.

City ofUnited kingdomInfanrix pediarixSmithkline beechamEmma walmsleyNational immunization programsNational immunization programs for bexseroUs centerValley forgeFirst half operatingDisease controlSpecialty medicinesWithin vaccinesGlaxo wellcome